1. Up Front

   Up Front 26 October 2023 Pages: 2187 - 2188

   

2. Quantifying beta cell function in the preclinical stages of type 1 diabetes

   • Alfonso Galderisi
   • Alice L. J. Carr
   • Colin Dayan

   Review Open access 15 September 2023 Pages: 2189 - 2199

   

3. The challenges of identifying and studying type 1 diabetes in adults

   • Nicholas J. Thomas
   • Angus G. Jones

   Review Open access 20 September 2023 Pages: 2200 - 2212

   

4. Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial

   • Merel M. Ruissen
   • José D. Torres-Peña
   • POWER2DM Consortium

   Article Open access 29 September 2023 Pages: 2213 - 2225

   

5. Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes

   • Pernille Svalastoga
   • Alba Kaci
   • Pål R. Njølstad

   Article Open access 05 October 2023 Pages: 2226 - 2237

   

6. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study

   • Benjamin N. Wadström
   • Kasper M. Pedersen
   • Børge G. Nordestgaard

   Article Open access 30 September 2023 Pages: 2238 - 2249

   

7. Identifying the severity of diabetic retinopathy by visual function measures using both traditional statistical methods and interpretable machine learning: a cross-sectional study

   • David M. Wright
   • Usha Chakravarthy
   • Ruth E. Hogg

   Article Open access 19 September 2023 Pages: 2250 - 2260

   

8. Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial

   • Sara J. Cromer
   • Tanayott Thaweethai
   • Deborah J. Wexler

   Article 16 September 2023 Pages: 2261 - 2274

   

9. Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank

   • Caiwei Tian
   • Charlyne Bürki
   • Chirag J. Patel

   Article Open access 20 September 2023 Pages: 2275 - 2282

   

10. High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment

    • Emily K. Sims
    • Susan M. Geyer
    • Kevan C. Herold

    Article 04 September 2023 Pages: 2283 - 2291

    

11. CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice

    • Angela J. T. Bosch
    • Lena Keller
    • Claudia Cavelti-Weder

    Article Open access 04 October 2023 Pages: 2292 - 2306

    

12. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy

    • Marja-Riitta Taskinen
    • Niina Matikainen
    • Jan Borén

    Article Open access 29 September 2023 Pages: 2307 - 2319

    

13. The metabolic response of human trophoblasts derived from term placentas to metformin

    • Jane L. Tarry-Adkins
    • India G. Robinson
    • Catherine E. Aiken

    Article Open access 05 September 2023 Pages: 2320 - 2331

    

14. Structural changes in Schwann cells and nerve fibres in type 1 diabetes: relationship with diabetic polyneuropathy

    • Xiaoli Hu
    • Christian Selmer Buhl
    • Pall Karlsson

    Article Open access 20 September 2023 Pages: 2332 - 2345

    

15. Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells

    • Benedetta Maria Bonora
    • Mario Luca Morieri
    • Gian Paolo Fadini

    Article Open access 15 September 2023 Pages: 2346 - 2355

    

16. Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes

    • Tomoya Mita
    • Naoto Katakami
    • Hirotaka Watada

    Article Open access 26 September 2023 Pages: 2356 - 2367

    

17. Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice

    • Jian-Ming Li
    • Xianyu Li
    • Sijun Yang

    Article 24 August 2023 Pages: 2368 - 2386

    

18. Presymptomatic type 1 diabetes and disease severity at onset

    • Josephine Schneider
    • Gita Gemulla
    • Angela Hommel

    Letter Open access 26 September 2023 Pages: 2387 - 2388

19. Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]

    • Sandra Hummel
    • Nadine Friedl
    • for the Fr1da Study Group

    Letter Open access 19 September 2023 Pages: 2389 - 2390